ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,541, issued on July 14, was assigned to Technion Research & Development Foundation Ltd. (Haifa, Israel).
"Curable fibrinogen and uses thereof" was invented by Dror Seliktar (Haifa, Israel) and Haneen Simaan-Yameen (Haifa, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "Conjugates of fibrinogen and a plurality of curable groups covalently attached thereto, and curable formulations comprising such conjugates, are provided. Also provided are three-dimensional objects (scaffolds) made of the conjugate or the curable formulation, for example, by additive manufacturing, and uses thereof in, for example, tissue healing and/or regeneration."
The pate...